Nu-Med Plus (NUMD) Return on Capital Employed Growth (3y) (2016 - 2025)
Nu-Med Plus (NUMD) Return on Capital Employed Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | - |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 370.00 |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | -9,022.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16,203.00 |
| Sep 30, 2025 | -8,885.00 |
| Jun 30, 2025 | -11,838.00 |
| Mar 31, 2025 | -27,179.00 |
| Dec 31, 2024 | -68,320.00 |
| Sep 30, 2024 | -235,950.00 |
| Jun 30, 2024 | 168,154.00 |
| Mar 31, 2024 | 72,748.00 |
| Dec 31, 2023 | 46,689.00 |
| Sep 30, 2023 | 58,003.00 |
| Jun 30, 2023 | 783,988.00 |
| Mar 31, 2023 | -2,367.00 |
| Dec 31, 2022 | -11,500.00 |
| Sep 30, 2022 | -25,286.00 |
| Jun 30, 2022 | -45,412.00 |
| Mar 31, 2022 | -130,615.00 |
| Dec 31, 2021 | 174,503.00 |
| Sep 30, 2021 | 349,646.00 |
| Jun 30, 2021 | -407,054.00 |
| Mar 31, 2021 | 124,638.00 |